| Author(s) | |
|---|---|
| Publisher | |
| Publication Year |
Drugs
Regulatory Capture and the Disabling of Drug Safety at Health Canada
From: Corporate Rules
$2.30
In this chapter, Michèle Brill-Edwards provides a behind-the-scenes look at how the Canadian government has quietly disabled the safety system for drugs in Canada. The Food and Drugs Act maintains the expectation that drugs will be useful and safe for their approved purpose and that citizens and their doctors will be fully informed by accurate sources of information about products based on research compelled by law and scrutinized by independent government medical scientists working in the public interest to protect the health of citizens and minimize potential harms. However, since the 1980’s we have been experiencing increasing measures for greater drug deregulation. Brill-Edward argues that examining nearly a century of drug regulatory history demonstrates that, to benefit from technological advances, societies need a permanent cohort of dedicated professionals authorized and paid to investigate and control both the promise and the harm of new medical advances, as strict regulations are in the interest of all Canadians.
